市場調查報告書
商品編碼
1587688
至 2030 年槐醣脂市場預測:按類型、配方類型、功能、應用和地區進行的全球分析Sophorolipids Market Forecasts to 2030 - Global Analysis By Type (Acidic Sophorolipids and Lactonic Sophorolipids), Formulation Type (Liquid Sophorolipids and Powdered Sophorolipids), Functionality, Application and by Geography |
根據 Stratistics MRC 的數據,2024 年全球槐醣脂市場規模為 5.3396 億美元,預計 2030 年將達到 8.0493 億美元,預測期內複合年成長率為 7.08%。
槐醣脂是一種生物界面活性劑,由某些酵母菌(如假絲酵母)透過發酵植物油和糖等可再生資源而產生。這種無毒且生物分解性的材料用於藥品、清潔劑、化妝品和農業等各個領域,並因其環保特性而受到關注。槐醣脂以其降低表面張力的能力而聞名,使其可用作配方中的穩定劑、清洗和乳化劑。
根據《生物技術進展》雜誌上發表的一項研究,槐醣脂因其低毒性、高生物分解性和有效的界面活性劑特性而成為最有前途的生物表面活性劑之一。研究還強調,槐醣脂可以將表面張力降低至 33 mN/m,使其在清潔劑和個人保健產品等各種應用中非常有效。
消費者對環保產品的興趣日益濃厚
消費者對環境問題以及合成化學物質對生態系統和人類健康造成的危害的認知不斷提高,正在推動對環保產品的需求。槐醣脂無毒、生物分解性,並且源自可再生資源,這使其成為傳統界面活性劑的替代品。此外,向永續性的轉變在個人護理和家庭清洗行業中尤為明顯,這些行業正在積極努力改進其產品,以滿足消費者對天然成分的偏好。
製造成本高
槐醣脂的生產成本比傳統的合成界面活性劑更高,因為它們通常需要複雜的發酵程序和專門的原料。這種價差可能會限制其吸引力,特別是在消費者和企業關注物有所值的市場中。此外,下游加工和精製的高成本進一步加劇了這個問題,使得槐醣脂很難與知名的化學界面活性劑進行價格競爭。
製藥和醫療產業的成長
槐醣脂在藥物傳輸系統和醫療應用中的廣泛使用預計將推動醫療藥品領域的顯著成長。由於其低毒性、生物相容性和抗菌特性,它可用於多種藥物配方,包括醫療設備和創傷護理產品的塗層。此外,該行業的發展為製造商提供了創造新產品和應用的豐富機會。
與人工界面活性劑的激烈競爭
槐醣脂市場的最大威脅是成熟的合成界面活性劑,因為它們具有經過驗證的性能和較低的製造成本。這些傳統的界面活性劑在許多領域都很成熟,包括工業應用、清潔劑和個人護理。此外,說服生產商和消費者從眾所周知的合成替代品轉向槐醣脂等生物基替代品是很困難的,特別是當成本和功能是決策的關鍵考慮因素時,如果是這樣,這是一項艱鉅的任務。正因為如此,市場不願意接受更現代、更環保的解決方案。
槐醣脂市場受到 COVID-19 大流行的嚴重影響,其主要原因是生產延誤、經濟不確定性和全球供應鏈中斷。北美、歐洲和亞洲的停產和公司倒閉阻礙了生產能力,減少了這些生物基界面活性劑的供應。儘管疫情的爆發將永續性和衛生作為重點,但各行業的審慎支出抑制了整體市場成長。然而,隨著行業逐步恢復營運,供應緊張開始緩解,特別是醫藥、個人護理等行業,對槐醣脂的新需求出現。
預計酸性槐醣脂部分在預測期內將是最大的
由於其廣泛的應用和有利的特性,酸性槐醣脂部分在槐醣脂市場中佔據主導地位。一些酵母菌種,特別是 Starmerella bidicola 的發酵,會產生酸性槐醣脂,眾所周知,槐醣脂是雙親性的,因此是有效的表面活性劑。酸性槐醣脂具有高度水溶性並具有強大的發泡特性,使其適用於生物修復、乳製品和化妝品等多種應用。此外,它們比合成界面活性劑更俱生物分解性且毒性更小,這使得它們越來越有吸引力,特別是隨著消費者對更綠色和更永續產品的偏好而改變。
預計皮膚調理劑細分市場在預測期內複合年成長率最高
在預測期內,槐醣脂市場的皮膚調理劑部分預計將以最高複合年成長率成長。個人保健產品(尤其是護膚配方)對安全高效成分的需求不斷成長,是這項擴張的關鍵驅動力。槐醣脂以溫和且高度保濕而聞名,是優秀的皮膚調理劑,可增強產品的性能而不刺激皮膚。此外,它能夠增加水合作用並提供光滑的質地,使其在乳液、乳霜和其他化妝品應用中非常受歡迎。
槐醣脂市場由歐洲主導。嚴格的環境法以及消費者和製造商對永續實踐的堅定承諾是這一優勢的關鍵因素。歐洲在槐醣脂市場處於領先地位,因為它專注於減少對石化產品的依賴並提高消費者對環保替代品的認知。此外,由於產品開發的進步和個人護理、農業和製藥等許多行業的應用不斷擴大,永續性仍然是重中之重,預計歐洲市場將進一步成長。
由於快速的工業化和對永續解決方案的興趣日益濃厚,槐醣脂市場預計將以亞太地區最高的複合年成長率成長。生物基界面活性劑擴大用於化妝品、藥品和農業,其中中國和印度等國家引領了這種擴張。該地區對綠色技術和環保意識的傾向進一步推動了對槐醣脂的需求,因為消費者和企業都在尋求傳統化學表面活性劑的環保替代品。此外,支持生物基產品的政府計畫也有望促進市場成長,亞太地區將成為未來幾年槐醣脂市場的主要參與企業。
According to Stratistics MRC, the Global Sophorolipids Market is accounted for $533.96 million in 2024 and is expected to reach $804.93 million by 2030 growing at a CAGR of 7.08% during the forecast period. Sophorolipids are a type of biosurfactant produced by certain yeast species, such as Candida bombicola, through the fermentation of renewable resources like vegetable oils and sugars. These non-toxic, biodegradable substances are utilized in a variety of sectors, such as pharmaceuticals, detergents, cosmetics, and agriculture, and have drawn notice for their eco-friendly qualities. Because of their well-known capacity to lower surface tension, sophorolipids are useful stabilizers, detergents, and emulsifiers in formulations.
According to a study published in the journal Biotechnology Advances, sophorolipids are among the most promising biosurfactants due to their low toxicity, high biodegradability, and effective surface-active properties. The study also highlights that sophorolipids can reduce surface tension to as low as 33 mN/m, making them highly effective in various applications such as detergents and personal care products.
Growing consumer interest in eco-friendly products
The demand for eco-friendly products is being driven by consumers growing awareness of environmental issues and the harm that synthetic chemicals cause to ecosystems and human health. Sophorolipids are appealing substitutes for conventional surfactants because they are non-toxic, biodegradable, and derived from renewable resources. Additionally, in the personal care and household cleaning industries, where companies are actively working to reformulate products to satisfy consumer preferences for natural ingredients, this shift towards sustainability is especially noticeable.
High costs of production
Sophorolipids are more expensive to produce than traditional synthetic surfactants because they frequently require intricate fermentation procedures and specialized raw materials. Their appeal may be limited by this price difference, particularly in markets where consumers and businesses place a high value on cost-effectiveness. Furthermore, this problem is made even worse by the high expenses of downstream processing and purification, which make it challenging for sophorolipids to compete on price with well-known chemical surfactants.
Growth in the pharmaceutical and healthcare industries
The growing use of sophorolipids in drug delivery systems and medical applications is anticipated to drive significant growth in the healthcare and pharmaceuticals segment. Because of their low toxicity, biocompatibility, and antimicrobial qualities, they can be used in a variety of pharmaceutical formulations, such as medical device coatings and wound care products. Moreover, the growth of this industry presents manufacturers with rich chances to create new products and applications.
Strong competition from artificial surfactants
Due to their well-established performance and lower production costs, established synthetic surfactants pose the biggest threat to the sophorolipids market. These traditional surfactants are well-established in a number of sectors, such as industrial applications, detergents, and personal care. Additionally, convincing producers and consumers to move from well-known synthetic alternatives to bio-based substitutes like sophorolipids is a difficult task, particularly when cost and functionality are important considerations when making decisions. Because of this, the market is hesitant to embrace more modern, environmentally friendly solutions.
The market for sophorolipids was greatly impacted by the COVID-19 pandemic, mostly due to delays in manufacturing, economic uncertainty, and disruptions in global supply chains. Production capacity was hampered by lockdowns and company closures in North America, Europe, and Asia, which reduced the supply of these bio-based surfactants. Overall market growth was constrained by cautious spending across industries, despite the pandemic's increased emphasis on sustainability and hygiene. However, a renewed need for sophorolipids arose as industries gradually resumed operations and supply constraints started to lessen, especially in industries like pharmaceuticals and personal care.
The Acidic Sophorolipids segment is expected to be the largest during the forecast period
Due to its many uses and advantageous characteristics, the acidic sophorolipid segment dominates the sophorolipids market. The fermentation of several yeast species, most notably Starmerella bombicola, yields acidic sophorolipids, which are known for being amphiphilic and thus making them efficient surfactants. Because of their greater water solubility and potent foaming properties, acidic sophorolipids are appropriate for a variety of applications, such as bioremediation, dairy, and cosmetics. Moreover, their increased biodegradability and decreased toxicity in comparison to synthetic surfactants add to their allure, especially as consumer preferences for environmentally friendly and sustainable products change.
The Skin Conditioning Agents segment is expected to have the highest CAGR during the forecast period
Over the course of the forecast period, the sophorolipids market's skin conditioning agents segment is anticipated to grow at the highest CAGR. The rising demand for safe and efficient ingredients in personal care products, especially skincare formulas, is the main driver of this expansion. Well-known for their skin-friendly and moisturizing qualities, sophorolipids are great skin conditioning agents that improve product performance without being harsh on the skin. Additionally, they are highly sought after in lotions, creams, and other cosmetic applications because of their capacity to enhance hydration and offer a smooth texture.
The market for sophorolipids is dominated by the European region. Strict environmental laws and a strong emphasis on sustainable practices by both consumers and manufacturers are the main drivers of this dominance. Europe is positioned as a leader in the sophorolipids market due to the region's dedication to lowering dependency on petrochemical-based products and growing consumer awareness of environmentally friendly alternatives. Furthermore, the European market is anticipated to grow even more as sustainability remains a top priority, propelled by advancements in product development and expanding applications in a number of industries, such as personal care, agriculture, and pharmaceuticals.
The market for sophorolipids is expected to grow at the highest CAGR in the Asia-Pacific region due to rapid industrialization and a growing focus on sustainable solutions. As bio-based surfactants are increasingly used in cosmetics, pharmaceuticals, and agriculture, nations like China and India are leading the way in this expansion. The demand for sophorolipids is further increased by the region's dedication to green technologies and environmental awareness, as both consumers and businesses look for environmentally friendly substitutes for conventional chemical surfactants. Moreover, government programs supporting bio-based products are also anticipated to support market growth, positioning Asia-Pacific as a major player in the sophorolipids market going forward.
Key players in the market
Some of the key players in Sophorolipids market include BASF SE, Evonik Industries AG, Unilever, Holiferm Limited, Allied Carbon Solutions Co., Ltd., Givaudan SA, Ferro Corporation, Biobar Pty Ltd., Tokyo Chemical Industry, Syngenta AG, Koninklijke DSM N.V., Saraya Co. Ltd, Dow Inc., Mg Intobio Co Ltd, Soliance, Henkel AG & Co. KGaA, Sabic and Kaneka Corporation.
In July 2024, BASF and ENGIE signed a 7-year Biomethane Purchase Agreement (BPA). Under the BPA, ENGIE will supply BASF with 2.7 to 3.0 terawatt hours of biomethane throughout the term of the agreement. BASF uses certified biomethane at its Ludwigshafen/Germany and Antwerp/Belgium sites as a sustainable alternative to fossil raw materials in its manufacturing process.
In May 2023, Dow and New Energy Blueopens announced a long-term supply agreement in North America in which New Energy Blue will create bio-based ethylene from renewable agricultural residues. Dow expects to purchase this bio-based ethylene, reducing carbon emissions from plastic production, and using it in recyclable applications across transportation, footwear, and packaging.
In January 2023, Holiferm Limited and Sasol Chemicals, a business unit of Sasol Ltd., announced collaboration to produce and market rhamnolipids and mannosylerythritol lipids (MELs). This collaboration expands the partnership announced in March 2022 between the two companies to develop and commercialise another biosurfactant product, sophorolipids.